Molecular epigenetic targets for liver diseases: current challenges and future prospects
Related Experiment Video
Updated: Feb 25, 2026

Cell Type-specific Gene Expression Profiling in the Mouse Liver
Published on: September 17, 2019
Robert Zeidler1, Bruno Leonardo de Freitas Soares1, Augustinus Bader1
1Centre for Biotechnology and Biomedicine, Department of Cell Techniques and Applied Stem Cell Biology, Medical Faculty of University of Leipzig, Deutscher Platz 5, D-04103 Leipzig, Germany.
Abstract:
Advanced chemotherapy fails to treat liver cancer but recent progress in understanding epigenetic modifications have witnessed promising clinical outcomes. Epigenetic alteration is the alteration of epigenomes (surrounding histone proteins) without changing the DNA sequence. Such epigenetic mechanisms include histone modifications such as methylation, acetylation, phosphorylation and sumoylation followed by changes in the genomic architecture. Current studies involving the understanding of small RNA molecules such as noncoding RNA and microRNA in modulating the chromatin architecture are explained in depth here, along with effects of some novel compounds from recent preclinical and clinical evidence. This review also discusses the current state-of-the-art strategies and the possible scope of investigation to improve the existing treatment methods for liver-related disorders.
Insights
Epigenetic modifications, like histone changes, offer new liver cancer treatments. Understanding noncoding RNAs and novel compounds can improve therapies for liver disorders.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Advanced chemotherapy shows limited efficacy in treating liver cancer.
- Recent advancements in understanding epigenetic modifications are yielding promising clinical outcomes.
- Epigenetic alterations involve changes in the epigenome, such as histone modifications, without altering the DNA sequence.
Purpose of the Study:
- To review the role of epigenetic modifications in liver cancer.
- To explore the impact of small RNA molecules (noncoding RNA and microRNA) on chromatin architecture.
- To discuss novel compounds and current strategies for improving liver disorder treatments.
Main Methods:
- Review of current literature on epigenetic modifications in liver cancer.
- Analysis of studies on noncoding RNA and microRNA in modulating chromatin.
- Examination of preclinical and clinical evidence for novel therapeutic compounds.
Main Results:
- Epigenetic mechanisms, including histone methylation, acetylation, phosphorylation, and sumoylation, influence genomic architecture.
- Small RNA molecules play a significant role in modulating chromatin structure.
- Novel compounds show potential in preclinical and clinical settings for liver-related disorders.
Conclusions:
- Epigenetic modifications represent a promising therapeutic avenue for liver cancer.
- Further investigation into small RNAs and novel compounds is crucial for advancing liver disorder treatments.
- Current strategies and future research scopes aim to enhance existing treatment methodologies for liver diseases.
More Related Videos
09:56Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
Published on: October 31, 2025
09:45Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins and mRNA into Freshly Isolated Primary Mouse Hepatocytes
Published on: June 2, 2022
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Targeted Cancer Therapies
There are several types of targeted therapies against...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cell Specific Gene Expression